Stoked Bio Licenses Global Rights for Novel Antibiotic from McMaster University

Enterololin uses a novel mechanism of action to attack the infection.New treatment has potential use in Crohn's Disease.License is under existing Research and Collaboration Agreement with McMaster.Hamilton, Ontario--(Newsfile Corp. - December 4, 2025) - Stoked Bio Inc., a Canadian biotechnology company focused on the development of novel anti-infectives and cancer therapeutics, announced today it has secured an exclusive, global license from McMaster University for the patents covering...

2025-12-04 9:12 AM EST